Testing of Korean natural drug approved by MFDS

Published: 2013-08-05 06:56:00

Updated: 2013-08-05 06:56:00

Kwang Dong Pharmaceutical Co. said Monday it has received from the Ministry of Food and Drug Safety to conduct Phase 1 clinical trial of a natural drug for the treatment of obesity.

The company said the approval comes after successful completion of preclinical studies on KD101, derived from Ea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK